SECTION I: APPENDIXES 17. S. Kõks, A. Soosaar, V. Võikar, V. Volke, M. Ustav, P.T. Männistö, M. Bourin, E. Vasar. Opioid antagonist naloxone potentiates anxiogenic-like action <strong>of</strong> cholecystokinin agonists in elevated plusmaze. Neuropeptides, 1998, 32(3); 235-240. 18. J. Kivastik Review: Paediatric reference values for spirometry. Clin Physiology, 1998 (6), 489-497. 19. Volke V, Soosaar A. Kõks S, Vasar E, Männistö PT (1998) L-arginine abolishes <strong>the</strong> anxiolytic-like effect <strong>of</strong> diazepam in <strong>the</strong> elevated plus-maze test in rats. European Journal <strong>of</strong> Pharmacology 351: 287-290. 20. P.Plakk, P. Liik, P.-H. Kingisepp Hot-wire anemometer for spirography. Med.Biol.Eng.Comput., 1998, 36, 17-21. 21. R.Raamat, J.Talts, K.Jagomägi, E.Länsimies Ma<strong>the</strong>matical modelling <strong>of</strong> non-invasive oscillometric finger mean blood pressure measurement by maximum oscillation criterion Med. Biol. Eng. Comp, 1999, 37, 784-788. 22. M. Bourin, M. Malinge, M.C. Colombel, E. Vasar Cholecystokinin receptor agonists block <strong>the</strong> jumping behaviour precipitated in morphine-dependent mice by naloxone. European Neuropsychopharmacology, 1999, 9, 37-43 23. V. Volke, G. Wegener, E. Vasar, R. Rosenberg Methylene blue inhibits hippocampal nitric oxide synthase activity in vivo. Brain Research, 1999, 826, 303-305. 24. S. Kõks, A. Soosaar, V. Võikar, M. Bourin, E. Vasar BOC-CCK-4, CCKB receptor agonist, antagonizes anxiolytic-like action <strong>of</strong> morphine in elevated plus-maze. Neuropeptides, 1999, 33, 63-69. 25. S. Kõks, M. Bourin, V. Võikar, A. Soosaar, E. Vasar Role <strong>of</strong> CCK in anti-exploratory action <strong>of</strong> paroxetine, 5-HT reuptake inhibitor. International Journal <strong>of</strong> Neuropsychopharmacology, 1999, 2, 9-16. 26. V. Võikar, A. Sooaar, V. Volke, S. Kõks, M. Bourin, P.T. Männistö, E. Vasar Apomorphine-induced behavioural sensitization in rats: individual differences, role <strong>of</strong> dopamine and NMDA receptors. European Neuropsychopharmacology, 1999, 9, 507-514. 27. Soosaar The morph<strong>of</strong>unctional strategies to find neural correlates <strong>of</strong> consciousness. In: Neuronal Bases and Psychological Aspects <strong>of</strong> Consciousness. London, World Scientific Press, 1999, 541- 545. 28. Wegener G, Volke V, Rosenberg R. (2000) Endogenous nitric oxide decreases hippocampal levels <strong>of</strong> serotonin and dopamine in vivo. British Journal <strong>of</strong> Pharmacology 130: 575-80. 29. R.Raamat, K.Jagomägi, J.Talts, P.-H.Kingisepp. Effect <strong>of</strong> Peripheral Vasoconstriction on <strong>the</strong> Beatto-Beat Measurement <strong>of</strong> Finger Blood Pressure. World Congress on Medical Physics and Biomedical Engineering, Chicago, 22-28. July 2000. 4 pages on CD. 30. R.Raamat, K.Jagomägi, J.Talts. Different Responses <strong>of</strong> Finapres and <strong>the</strong> Oscillometric Finger Blood Pressure Monitor During Intensive Vasomotion. Journal <strong>of</strong> Medical Engineering & Technology, 2000, 24, 3, 95-101. 31. A.Nurmekivi, P.-H.Kingisepp. Capacity <strong>of</strong> <strong>the</strong> respiratory system and <strong>the</strong> potential to influence it. Modern athlete and coach, 2000, 38, 8-12. 32. S. Kõks, P.T. Männistö, M. Bourin, J. Shlik, V. Vasar, E. Vasar Cholecystokinin (CCK) in <strong>the</strong> rat plus-maze model <strong>of</strong> anxiety B a possible relation to human disorders. Journal <strong>of</strong> Psychiatry & Neuroscience, 2000, 25, 33-42. 33. A. Veraksits, I. Bileviciute-Ljungar, J. Maaroos, E. Vasar, T. Lundeberg Neuronal mechanisms contribute to corticotropin-releasing factor-induced anti-oedema effect in <strong>the</strong> rat hind paw. Neuropeptides, 2000, 34, 129-134. 34. Wegener G, Volke V, Bandpey Z, Rosenberg R. (2001) Nitric oxide modulates lithium-induced conditioned taste aversion. Behavioral Brain Research 118: 195-200. PAPERS IN ESTONIAN JOURNALS 1. Jagomägi K., Viigimaa M., Hendrikson E., Talts J., Raamat R., Teesalu R. Arteriaalse vererõhu ja südame löögisageduse variaabelsuse määramine funktsionaalsete testide ajal. südamelihase infarkti ägedas faasis. Eesti Arst, 1996, 2, 105-108 62. J. Kivastik, P.-H. Kingisepp Voolu-mahu lingu näitajate hajuvus laste kordusuuringutel. Eesti Arst, 1996, 5, 410-412. 63. P.-H. Kingisepp, J. Kivastik Lämmastiku üksihingamistesti rakendamisest kopsude funktsionaalse seisundi hindamisel. Eesti Arst, 1997, 5, 396-400. 64. P.-H.Kingisepp, V.Pert Kopsude difusioonivõime määramine CO üksikhingamispeetuse meetodil Eesti Arst 1998, 6, 499-501. 65. R.Raamat, J.Talts, K.Jagomägi. Theoretical study <strong>of</strong> discrepancies in estimation <strong>of</strong> mean blood pressure by Marey’s criterion. Proc. Estonian Acad. Sci. Eng., 1999, 5, 4, 281-292. 66. P.-H.Kingisepp Georg Kingisepa meditsiiniõpingutest Heidelbergis. Eesti Arst, 1999, 2, 166-171. 82
PHYSIOLOGY 67. J.Kivastik, P.-H.Kingisepp Voolu-mahu lingu näitajad tervetel ja hingamiskaebustega lastel. Eesti Arst, 1999, 4, 291-294. SUBMITTED PAPERS 1. K.Jagomägi, R.Raamat, J.Talts. Effect <strong>of</strong> Peripheral Vasomotion on <strong>the</strong> Measurement <strong>of</strong> Finger Blood Pressure. Blood Pressure Monitoring. 2001, 6, (Accepted). 2. P.-H.Kingisepp, K.Jagomägi, R.Raamat. Changes <strong>of</strong> heart rate and blood pressure in registration <strong>of</strong> forced respiration flow-volume loop. Clinical Physiology, 2001, 21, (Accepted) 3. R.Raamat, K.Jagomägi, J.Talts, E.Länsimies, J.Jurvelin, P.Kolari. Continuous mean arterial pressure measurement in <strong>the</strong> fingers: <strong>the</strong> influence <strong>of</strong> hand local cooling. Journal <strong>of</strong> Medical Engineering and Technology, 2001 (Accepted). 4. R.Raamat, R.Lõhmus, A.Lõhmus, P.Liblik, M.Lobjakas, L.Montelius, J.Lindahl, D.Erts, H.Olin. Piezoresonance driver for positioning in scanning probe microscope in a wide temperature range. Ferroelectrics. Submitted. 5. J.Kivastik, P.-H.Kingisepp Spirometric reference values in Estonian schoolchildren, Clinical Physiology, submitted. 6. Kõks S, Beljajev S, Koovit I, Abramov U, Bourin M, Vasar E 8-OH-DPAT, but not deramciclane, antagonizes <strong>the</strong> anxiogenic-like action <strong>of</strong> paroxetine in elevated plus-maze. Psychopharmacology, 2000 (online publication 14/12/2000). 7. Võikar V, Kõks S, Vasar E, Rauvala H Strain and gender differences in <strong>the</strong> behavior <strong>of</strong> mouse lines commonly used in transgenic studies. Physiology & Behavior, 2001 (in press). 8. S. Kõks, U. Abramov, T. Sillat, A. Veraksitš, M. Bourin 2 , T. Matsui 1 , E. Vasar CCK2 receptordeficient mice have increased sensitivity <strong>of</strong> dopamine D2 receptors. Neuropeptides, 2001 (submitted). TEXTBOOKS AND MANUALS 1. J.Kivastik, P.-H.Kingisepp. “Lung function testing in children”, Tartu 1999, pp. 1–28 (in Estonian, guidelines for <strong>the</strong> assessment <strong>of</strong> flow-volume curves). 2. R.F.Schmidt, G.Thews Inimese füsioloogia, Tartu 1997 (ISBN 9985-60-309-5) P.-H.Kingisepa tõlgitud peatükid 7., 8. (lk 176-206), 15. (lk 340-348), 21, 22, 23, 24 (lk 574-659) ja indeksi koostamine lk. 847-880 3. P.-H.Kingisepp (toimetaja). Koostajad: K.Jagomägi, P.-H.Kingisepp, V.Pert, A.Soosaar, I.-O.Vaasa Füsioloogia praktikum I Tartu Ülikooli Kirjastus Tartu 1999, 125 lk. 4. P.-H.Kingisepp Inimese füsioloogia Atlex Tartu 2000, 265 lk. 83